share_log

Hill Street Reports FY 2022 Q2 & Year-to-Date Results, Expansion of DehydraTECH(TM) Licensing Business into New States, and Ticker Change to Reflect Hill Street's Growth and Evolution

Hill Street Reports FY 2022 Q2 & Year-to-Date Results, Expansion of DehydraTECH(TM) Licensing Business into New States, and Ticker Change to Reflect Hill Street's Growth and Evolution

Hill Street報告2022財年第二季度和今年迄今的業績、DehyTECH(TM)許可業務向新州的擴展,以及反映Hill Street公司增長和演變的Ticker變化
newsfile ·  2022/03/01 21:40

Highlights:

重點:

  • Increased gross profit for the six months ended December 31, 2021 by 12% Year over Year with a 9% increase in net revenue Year over Year
  • Grew gross profit margin for the six months ended December 31, 2021 from 42% to 48% Year over Year, reflecting the improved financial impact of the DehydraTECH™ licensing business
  • Expanded rights in Illinois and Massachusetts to existing partner Dehydr8, LLC for licensing of DehydraTECH™ fast-acting cannabinoid delivery system technology to IL and MA contract manufacturers and licensed producers for B2B and B2C THC applications
  • Intends to obtain approval of the TSX Venture Exchange to change the Company's ticker symbol from "BEER" to "HILL", to reflect the Company's growth and evolution
  • 截至2021年12月31日的6個月毛利潤同比增長12%,淨收入同比增長9%
  • 截至2021年12月31日的6個月,毛利率同比增長42%至48%,反映出DehyTECH™許可業務的財務影響有所改善
  • 擴大了在伊利諾伊州和馬薩諸塞州的現有合作伙伴Deah8,LLC的權利,向IL和MA合同製造商以及B2B和B2C THC應用的特許生產商許可DehyTECH™快速作用大麻遞送系統技術
  • 擬獲得多倫多證券交易所創業板批准,將公司股票代碼由“BEAR”改為“HILL”,以反映公司的成長和發展

Toronto, Ontario--(Newsfile Corp. - March 1, 2022) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company") reported its fiscal year 2022 second quarter results for the three-month and six-month periods ended December 31, 2021. A complete set of financial statements and Management's Discussion & Analysis has been filed at . All dollar figures are quoted in Canadian dollars unless otherwise stated.

安大略省多倫多-(Newsfile Corp.-2022年3月1日)-Hill Street Beverage Company Inc.(多倫多證券交易所股票代碼:BEAR)(“山街“或”公司“)報告了截至2021年12月31日的三個月和六個月期間的2022財年第二季度業績。完整的財務報表和管理層的討論和分析已提交到。除非另有説明,所有美元數字均以加元報價。

HIGHLIGHTS OF SECOND QUARTER BUSINESS OPERATIONS

第二季度業務運營亮點

Hill Avenue Cannabis Technologies continued its expansion into new geographic markets and with new product formats

Hill Avenue Cannabis Technologies繼續向新的地理市場和新的產品模式擴張

The Company expanded the reach of a number of its DehydraTECH™ licensees as the licensees introduced their popular DehydraTECH™-powered products into new states and launched new products in the quarter. In FY2022 Q2, Nuka Enterprises LLC (1906)'s best-selling signature line of fast-acting swallowable THC pills (known as Drops) hit shelves in Arizona, and Cannadips launched a THC version of their popular original CBD pouches in California.

該公司擴大了一些DehyTECH™被許可人的覆蓋面,因為這些被許可人在本季度向新的州推出了他們廣受歡迎的DehyTECH™驅動的產品,並推出了新產品。在2022財年第二季度,Nuka Enterprise LLC(1906年)最暢銷的THC速效吞嚥藥丸(稱為Drops)系列在亞利桑那州上架,而Cannadips在加利福尼亞州推出了其廣受歡迎的原始CBD藥袋的THC版本。

Added Distribution of Hill Avenue Cannabis Brands' (V)ia Regal beyond Ontario into new provinces British Columbia and Northwest Territories

增加了Hill Avenue Cannabis Brands‘s(V)ia Regal在安大略省以外的新省份不列顛哥倫比亞省和西北地區的分銷

In FY2022 Q2, Hill Street's co-packing partner Molecule Inc. secured orders from the provincial cannabis boards of British Columbia and the Northwest Territories for the original (V)ia Regal Pink Grape Sparkler and the newly-launched (V)ia Regal White Grape Sparkler, both premium cannabis-infused sparklers made from grapes imported from European vineyards.

在2022財年第二季度,Hill Street的聯合包裝合作伙伴Molecal Inc.從不列顛哥倫比亞省和西北地區的省級大麻委員會獲得了原始(V)ia Regal粉色葡萄Sparkler和新推出的(V)ia Regal白葡萄Sparkler的訂單,這兩款優質注入大麻的汽水都是用從歐洲葡萄園進口的葡萄製成的。

Submitted application for a New Health Canada Cannabis Research License and continued progress on securing a Cannabis Processing License for the Ontario Lucknow Facility

提交了新的加拿大衞生部大麻研究許可證申請,並在為安大略省勒克瑙設施獲得大麻加工許可證方面繼續取得進展

The Company submitted an application for a Health Canada research license for its Lucknow cannabis facility in Mississauga, Ontario and also continued preparations for obtaining the Health Canada Standard Processor License for the facility, which will enable the Company to produce DehydraTECH™ fast-acting cannabinoid powder for potential B2B and B2C sales in Canada. The Company has begun construction at the facility, but delays related to municipal permits for the build-out are impacting the timing for submission of that Standard Processor License application to Health Canada.

該公司為其位於安大略省密西索加的勒克瑙大麻設施提交了加拿大衞生部研究許可證的申請,並繼續為獲得該設施的加拿大衞生部標準加工商許可證做準備,這將使該公司能夠為加拿大潛在的B2B和B2C銷售生產脱氫TECH™速效大麻素粉。該公司已經開始在該設施建設,但與擴建市政許可有關的延誤正在影響向加拿大衞生部提交標準處理器許可證申請的時間。

Permanent CEO named subsequent to the quarter

本季度後任命的永久首席執行官

Subsequent to the end of Q2, on January 6, 2022, the Company announced the appointment of Craig Binkley as CEO. Binkley had been operating in the interim Co-CEO role along with fellow board member Lori Senecal since February 9, 2021. Lori Senecal has transitioned out of the interim Co-CEO role and will continue in her Board of Director role.

在第二季度結束後,即2022年1月6日,該公司宣佈任命克雷格·賓克利(Craig Binkley)為首席執行官。自2021年2月9日以來,賓克利一直與董事會成員洛裏·塞內卡爾(Lori Senecal)一起擔任臨時聯席首席執行官。洛裏·塞內卡爾已經辭去臨時聯席首席執行官一職,將繼續擔任董事董事會的職務。

FINANCIAL HIGHLIGHTS FOR THE SIX MONTHS ENDING DECEMBER 31, 2021

截至2021年12月31日的六個月的財務摘要

Financial results for the six months year-to-date show significant improvements that reflect the growing impact of the DehydraTECH™ business on the Company's financial fundamentals.

今年到目前為止的6個月的財務業績顯示出重大改善,這反映出DehyTECH™業務對公司財務基本面的影響越來越大。

Net revenue increased 9% for the six-month period ending December 31, 2021 compared to the same period prior year, while gross profit increased 12% and gross profit margin improved six points from 42% to 48%. After adjusting for the impact of discontinued alcohol-free beer operations and inventory valuation adjustments made in the first half of FY 2021, net revenue for the first six months of FY 2022 increased 13%, while gross profit increased a full 30% and gross profit margin improved nine points from 39% to 48% for the six-month period.

在截至2021年12月31日的六個月裏,淨收入同比增長9%,毛利潤增長12%,毛利率從42%提高到48%,增幅為6個百分點。在對2021財年上半年停產的無酒精啤酒業務和庫存估值調整的影響進行調整後,2022財年前六個月的淨收入增長了13%,毛利潤增長了整整30%,毛利率從39%提高到48%,增幅為9個百分點。

"The year-to-date performance continued to exhibit the transformative power of our DehydraTECH™ licensing business on the overall financial measures of Hill Street", commented Craig Binkley, CEO of Hill Street. "The consolidated revenues, gross profit and gross profit margin are all improved by the escalating impact of this critical growth driver".

希爾街首席執行官克雷格·賓克利評論説:“今年到目前為止,我們的DehyTECH™許可業務在希爾街的整體財務措施上繼續顯示出變革性的力量。”“合併營收、毛利率和毛利率都受到這一關鍵增長動力不斷升級的影響的改善。”

Q2 FINANCIAL HIGHLIGHTS

第二季度財務亮點

While the six-month year-to-date financial results show strong positive trends, second quarter comparisons to year ago were negatively impacted by a quarterly shift in alcohol-free beverage revenues in the prior year.

雖然今年到目前為止的6個月的財務業績顯示出強勁的積極趨勢,但與去年同期相比,第二季度受到了前一年無酒精飲料收入季度變化的負面影響。

Q2 FY21 was an extraordinary quarter for Hill Street alcohol-free beverage revenues, as sales were shifted from Q1 FY21 and elevated dramatically beyond normal by the impact of retailers and distributors restocking empty shelves and pipeline inventories that were emptied by global pandemic and supply chain issues in Q1 FY21. Comparative revenues year ago also included the alcohol-free beer business that has since been discontinued.

對於Hill Street無酒精飲料收入來説,21財年第二季度是一個非同尋常的季度,因為銷售額從21財年第一季度轉移到了正常水平,原因是零售商和分銷商重新進貨空置貨架和管道庫存的影響,這些庫存在21財年第一季度因全球流行病和供應鏈問題而被清空。一年前的可比收入還包括後來停產的不含酒精啤酒業務。

As a result of the quarterly revenue shift and the discontinuation of alcohol-free beer, consolidated net revenues for Q2 FY22 declined 32% vs. Q2 prior year, moderating the six-month net revenue growth to 9%. After the quarterly shift and recovery in inventories, future net revenues are expected to reflect positive category trends in alcohol free wine and growth for the fiscal year.

由於季度收入的轉變和不含酒精啤酒的停產,22財年第二季度的合併淨收入比去年第二季度下降了32%,使連續6個月的淨收入增長放緩至9%。在季度轉移和庫存回升之後,預計未來的淨收入將反映出無酒精葡萄酒的積極類別趨勢和本財年的增長。

The quarterly shift in revenue also resulted in gross profit declining 33%, moderating the six-month gross profit gain to 12%. The increasing importance of the DehydraTECH™ licensing business allowed the Q2 gross profit margin to remain equal to year ago at 44%, although below the 48% margin for the full six-month period ending December 31, 2021.

收入的季度變化也導致毛利潤下降33%,將6個月的毛利潤增長放緩至12%。DehyTECH™許可業務的重要性日益增加,使得第二季度毛利率與去年同期持平,為44%,但低於截至2021年12月31日的6個月的48%。

RESULTS OF OPERATIONS

行動結果

The following table summarizes certain financial information of the Company for the three months and six months ended December 31, 2021, and the three months and six months ended December 31, 2020.

下表彙總了本公司截至2021年12月31日的三個月和六個月以及截至2020年12月31日的三個月和六個月的某些財務信息。

Consolidated Results for the Period Ended Quarter Ended
 December 31,
2021
Quarter Ended
December 31,
 2020
Six Months Ended
December 31,
2021
Six Months Ended
December 31,
2020
Gross Revenue $576,622 $875,529 $1,237,105 $1,259,979
Chargebacks, finance fees, and listing fees -$67,885 -$129,780 -$123,629 -$239,518
Net Revenue $508,737 $745,749 $1,113,476 $1,020,461
Direct Costs -$252,280 -$363,840 -$522,597 -$492,546
Gross profit $256,457 $381,909 $590,879 $527,915
Operating Expenses (excl. One-time & non-Cash) $794,938 $757,466 $1,444,954 $1,208,186
Other One-time Expenses $0 $19,337 $16,146 $23,837
Non-Cash Expenses $187,291 $88,891 $406,592 $255,513
Loss before other Income (Expense) -$725,772 -$483,785 -$1,276,813 -$959,620
Other income (Expenses)        
Foreign exchange gain (loss) $7,872 -$3,497 $9,114 -$1,980
(Loss) gain on Settlement of liability -$2,933 $6,730 -$2,720 $6,730
Loss) gain on fair value of Consideration $20,945 $0 -$14,471 $0
Write-off of inventory -$2,522 -$0 -$20,579 -$1,535
Other Income $2,934 $30 $6,434 $30
Loss and comprehensive loss for the period -$699,476 -$480,522 -$1,299,036 -$956,375
Basic and diluted loss per common share ($0.00) ($0.00) ($0.01) ($0.01)
Weighted average number of common shares outstanding 212,294,452 122,399,917 210,647,548 117,289,721
截至該期間的綜合業績 截至的季度
十二月三十一日,
2021
截至的季度
十二月三十一日,
2020
截至六個月
十二月三十一日,
2021
截至六個月
十二月三十一日,
2020
總收入 $576,622 $875,529 $1,237,105 $1,259,979
按存儲容量使用計費、財務費用和上市費 -$67,885 -$129,780 -$123,629 -$239,518
淨收入 $508,737 $745,749 $1,113,476 $1,020,461
直接成本 -$252,280 -$363,840 -$522,597 -$492,546
毛利 $256,457 $381,909 $590,879 $527,915
運營費用(不包括一次性和非現金) $794,938 $757,466 $1,444,954 $1,208,186
其他一次性費用 $0 $19,337 $16,146 $23,837
非現金費用 $187,291 $88,891 $406,592 $255,513
扣除其他收入(費用)前的虧損 -$725,772 -$483,785 -$1,276,813 -$959,620
其他收入(費用)
匯兑損益 $7,872 -$3,497 $9,114 -$1,980
(損失)清償責任的收益 -$2,933 $6,730 -$2,720 $6,730
損失)公允對價收益 $20,945 $0 -$14,471 $0
存貨核銷 -$2,522 -$0 -$20,579 -$1,535
其他收入 $2,934 $30 $6,434 $30
本期損失和綜合損失 -$699,476 -$480,522 -$1,299,036 -$956,375
每股普通股基本和攤薄虧損 ($0.00) ($0.00) ($0.01) ($0.01)
已發行普通股加權平均數 212,294,452 122,399,917 210,647,548 117,289,721

OTHER ANNOUNCEMENTS

其他公告

Signed new DehydraTECH™ Licensing Agreements with existing Michigan partner DeHydr8, LLC ("D8") for expansion of D8's rights into Illinois and Massachusetts for potential B2B and B2C applications

與現有的密歇根州合作伙伴Dehydr8,™(“D8”)簽署了新的DehyTECH許可協議,將D8的權利擴展到伊利諾伊州和馬薩諸塞州,用於潛在的B2B和B2C應用

Based on the success of D8's team since acquiring DehydraTECH™ rights in Michigan in signing top-quality Michigan licensed producers to produce THC products powered by DehydraTECH™, the Company is pleased to announce that it has expanded the reach of D8's DehydraTECH™ rights to add the new states of Illinois and Massachusetts.

在獲得密歇根州DehyTECH™授權後,D8的團隊成功簽約了密歇根州授權的頂級生產商生產由DehyTECH™驅動的THC產品,公司高興地宣佈,它已經擴大了D8的DehyTECH™授權的覆蓋範圍,增加了伊利諾伊州和馬薩諸塞州。

Granting DehydraTECH™ rights to D8 in Illinois and Massachusetts represent further steps that the Company is taking to rapidly mobilize and monetize the patented DehydraTECH™ technology by deploying a state-by-state US rollout model to continue to accelerate the Company's financial and operational progress. Hill Street and D8 have used their joint experiences gained in Michigan to create a scalable operating model for state-by-state expansion of the DehydraTECH™ licensing business that progresses from start to monetization over an approximately 5-month period.

授予DehyTECH™公司在伊利諾伊州和馬薩諸塞州D8的經營權,代表着該公司正在採取進一步措施,通過在美國各州部署推廣模式,迅速動員DehyTECH™專利技術並將其貨幣化,以繼續加快公司的財務和運營進展。Hill Street和D8利用他們在密歇根州獲得的聯合經驗,創建了一個可擴展的運營模式,用於在大約5個月的時間內,在各州擴展DehyTECH™許可業務,從開始到貨幣化。

Approval Sought from TSX Venture Exchange for Ticker Change from "BEER" to "HILL"

尋求多倫多證券交易所創業板批准將Ticker從“啤酒”改為“Hill”

The Company is pleased to announce that it intends to obtain the approval of the TSX Venture Exchange to change the Company's ticker symbol from "BEER" to "HILL". The Company expects that its common shares will begin trading on the TSX Venture Exchange under the new symbol "HILL" at market open on March 3, 2022.

本公司高興地宣佈,它打算獲得多倫多證券交易所創業板的批准,將本公司的股票代碼由“BEAR”改為“HILL”。該公司預計其普通股將於2022年3月3日開始在多倫多證券交易所創業板交易,新代碼為“HILL”。

This ticker change reflects the Company's growth and evolution beyond the domestic beverage business towards building a global, multi-business company pioneering the space where premium crafted consumer products meet bioscience.

股票代碼的這一變化反映了該公司的增長和發展,超越了國內飲料業務,朝着建立一家全球多業務公司的方向發展,開創了優質精心製作的消費產品與生物科學相結合的領域。

No action is required by existing shareholders with respect to the ticker symbol change and the CUSIP/ISIN numbers assigned to the Company's common shares will not be changed.

現有股東不需要就股票代碼的改變採取任何行動,分配給公司普通股的CUSIP/ISIN號碼也不會改變。

Re-Filing of FY 2022 Q1 Financial Statements

重新提交2022財年第一季度財務報表

The Company also announces today that it has re-filed its unaudited condensed interim consolidated financial statements for the three-month period ended September 30, 2021 in order to incorporate a notice advising the reader that the statements have not been reviewed by an auditor. The re-filed financial statements replace and supersede the previously filed original financial statements filed on November 29, 2021 and will be available on SEDAR on March 1, 2022.

該公司今天還宣佈,它已經重新提交了截至2021年9月30日的三個月的未經審計的簡明中期綜合財務報表,以便加入一份通知,告知讀者這些報表沒有經過審計師的審查。重新提交的財務報表取代和取代了之前提交的2021年11月29日提交的原始財務報表,並將於2022年3月1日在SEDAR上提供。

About Hill Street Beverage Company Inc. (TSXV: BEER)

關於希爾街飲料公司(多倫多證券交易所代碼:BEAR)

Hill Street Beverage Company Inc. is a progressive non-alcoholic beverage and cannabis solutions company. We are pioneering the space where craft consumer products meet bioscience by combining our deep CPG expertise and our rights to use Lexaria Bioscience Corp.'s ground-breaking DehydraTECH™ patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

希爾街飲料公司(Hill Street Beverage Company Inc.)是一家進步的非酒精飲料和大麻解決方案公司。通過將我們深厚的CPG專業知識和我們的使用權相結合,我們正在開創工藝消費品與生物科學相結合的領域。利卡里亞生物科學公司(Lexaria Bioscience Corp.)開創性的脱氫技術™大麻成分的產品開發、許可和B2B銷售的專利組合。

Hill Street Beverages brands include Vin(Zero) alcohol-free wines and Hill Street Craft Brewed Lager, and have won numerous medals and accolades around the world. Hill Avenue Cannabis Brands include (V)ia Regal Pink and White Grape Sparklers.

山街飲料品牌包括Vin(零)不含酒精葡萄酒和希爾街手工釀造的啤酒,並在世界各地贏得了無數的獎牌和讚譽。希爾大道大麻品牌包括(V)富豪國際酒店(Ia Regal)粉色和白色葡萄閃閃發光。

For more information on our business activities or to check out Hill Street's award-winning alcohol-free line-up and order product to be delivered straight to your home go to .

欲瞭解更多有關我們業務活動的信息或查看希爾街的屢獲殊榮的不含酒精產品陣容和訂單產品可直接送到您的家中。

For more information:

瞭解更多信息:

Craig Binkley, Chief Executive Officer
craig@hillstreetbevco.com.

克雷格·賓克利(Craig Binkley),首席執行官
地址:Craig@hillstreetbevco.com

FORWARD-LOOKING STATEMENTS

前瞻性陳述

Statements in this press release may contain forward-looking information. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "would", "anticipate", "expects", and similar expressions. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances, such as future availability of capital on favourable terms, may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities law.

本新聞稿中的陳述可能包含前瞻性信息。本新聞稿中任何非歷史事實的陳述均可被視為前瞻性陳述。前瞻性陳述通常由諸如“可能”、“應該”、“將”、“預期”、“預期”以及類似的表達方式來識別。提醒讀者,在準備任何前瞻性信息時使用的假設可能被證明是不正確的。由於許多已知和未知的風險、不確定性和其他因素,其中許多不是公司所能控制的,諸如未來以有利條件獲得資本等事件或情況可能導致實際結果與預測的結果大不相同。提醒讀者不要過度依賴任何前瞻性信息。這些信息雖然在準備時被管理層認為是合理的,但可能被證明是不正確的,實際結果可能與預期的大不相同。本新聞稿中包含的前瞻性陳述明確受本警告性聲明的限制。本新聞稿中包含的前瞻性陳述是截至本新聞稿發佈之日作出的。除非證券法要求,否則公司不承擔公開更新或修改任何包含的前瞻性陳述的義務,無論是由於新信息、未來事件還是其他原因。

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Not for dissemination in the United States.

不能在美國傳播。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論